Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Champions Oncolog
(NQ:
CSBR
)
4.230
-0.020 (-0.47%)
Streaming Delayed Price
Updated: 12:31 PM EDT, Sep 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
10,470
Open
4.050
Bid (Size)
4.170 (1)
Ask (Size)
4.310 (1)
Prev. Close
4.250
Today's Range
4.050 - 4.230
52wk Range
3.970 - 7.130
Shares Outstanding
13,415,066
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024
September 09, 2024
Via
ACCESSWIRE
CSBR Stock Earnings: Champions Oncology Beats EPS, Beats Revenue for Q4 2024
July 18, 2024
CSBR stock results show that Champions Oncology beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024.
Via
InvestorPlace
Performance
YTD
-26.94%
-26.94%
1 Month
-4.51%
-4.51%
3 Month
-9.23%
-9.23%
6 Month
-24.73%
-24.73%
1 Year
-36.01%
-36.01%
More News
Read More
Champions Oncology Reports Quarterly Revenue of $14.0 Million
July 18, 2024
Via
ACCESSWIRE
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024
July 11, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's Intraday Session
June 10, 2024
Via
Benzinga
Champions Oncology: Q3 Earnings Insights
March 12, 2024
Via
Benzinga
Earnings Outlook For Champions Oncology
March 11, 2024
Via
Benzinga
Recap: Champions Oncology Q2 Earnings
December 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 05, 2024
Via
Benzinga
Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development
June 04, 2024
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.0 Million
March 12, 2024
Via
ACCESSWIRE
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
March 07, 2024
Via
ACCESSWIRE
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024
March 06, 2024
Via
ACCESSWIRE
Earnings Scheduled For March 12, 2024
March 12, 2024
Via
Benzinga
Insiders Buying Solid Biosciences And 2 Other Stocks
January 16, 2024
Via
Benzinga
Insiders Buying Tilly's And 2 Other Stocks
January 10, 2024
Via
Benzinga
Why Is RiskOn International (ROI) Stock Up 28% Today?
December 13, 2023
Via
InvestorPlace
CSBR Stock Earnings: Champions Oncology Beats EPS, Misses Revenue for Q2 2024
December 12, 2023
Via
InvestorPlace
Champions Oncology Reports Quarterly Revenue of $11.6 Million
December 12, 2023
Via
ACCESSWIRE
Earnings Scheduled For December 12, 2023
December 12, 2023
Via
Benzinga
Johnson Controls, Oracle And 3 Stocks To Watch Heading Into Tuesday
December 12, 2023
Via
Benzinga
Investor Optimism Improves Further Ahead Of Inflation Data; Dow Gains For Third Straight Day
December 12, 2023
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023
December 04, 2023
Via
ACCESSWIRE
Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification
November 02, 2023
Via
ACCESSWIRE
Champions Oncology Announces the Addition of Brady Davis as President
October 17, 2023
Via
ACCESSWIRE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.